Navigation Links
Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
Date:3/27/2008

p>-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation;

-- the Company's ability to retain compliance with the NASDAQ's listing

qualifications; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2007 and its most recent quarterly report on Form 10-Q.

CONTACT:

Nichol Harber

Genta Investor Relations

908-286-3980

info@genta.com


'/>"/>
SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Auditors for Genta Incorporated Express Going Concern Qualification
2. Genta Announces Senior Management Changes
3. Genta Announces Common Stock Offering of Approximately $3.1 Million
4. Genta Incorporated to Present at the BIO CEO & Investor Conference
5. Genta Receives Notice of Non-Compliance With NASDAQ Rule
6. Genta Receives NASDAQ Non-Compliance Notice
7. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
8. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
9. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
10. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
11. Syngenta Licenses Chromatin Gene Stacking Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
..., Contributed by James V. Anderson and Char... of Food and Agricultural Sciences, , ...lin Heavy Chain Binding Proteins, also known as GR...-luminal proteins and members of the , HS...ort and folding process , of proteins inv...
..., Contributed by Alan T. Bakalinsky Departm...gon State University, Corvallis, OR 97331-6602, ...files of wine strains of Saccharomyces cerevisiae ...boratory karyotype. Qualitative analysis , ...the wine strains are aneuploid , and two ...
... , Marie Nguyen and William Strong, Bi...e, Hercules, CA 94547 USA , , I...yacrylamide gel electrophoresis (SDS-PAGE) , ...in separation. However, , this traditiona...and several , hours to complete. New micr...
... , Introduction , Amplific... (PCR) is a , highly sensitive method cap... just a single molecule. 1 Because of the ... carry-over product from previous reactions can re... Carry-over contamination can be avoided by using ...
Other Biology Technology:A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 2A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 3A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 4A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 5Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 2Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 3Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 4Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 5Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 6Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 2Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 3Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 4Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 5Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 6Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 7Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 8Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 9Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 10Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 11Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 12Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 13Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:7/24/2008)...ne researchers have found a molecular link between...lism. The discovery reveals new possibilities for ...ed diseases. , Paolo Sassone-Corsi, Distinguishe...leagues have identified that an essential protein ...hythms, works in balance with another protein call...
(Date:7/24/2008)...cture Proteins (NSP), a new family of genes discov...ncer Research and Molecular Medicine in Temple Uni... be involved in apoptosis or programmed cell death...li Sang, then a doctoral student at the University...n University and the Cardeza Foundation, and Anton...
(Date:7/24/2008)...e typhoon in Taiwan buries as much carbon in the o...r rains in that country all year long combined. ,...study published in a recent issue of the journal ...ne the chemistry of stream water and sediments tha... happening at full force -- will help scientists d...
(Date:7/23/2008)...08 One of the reasons people on low-carbohydrate ...take of fructose, a type of sugar that can be made...at UT Southwestern Medical Center. , Dr. Eliza...ion and lead author of a study appearing in a curr...team,s findings suggest that the right type of car...
Breaking Biology News(10 mins):Circadian rhythm-metabolism link discovered 2Novel structure proteins could play a role in apoptosis 2Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Limiting fructose may boost weight loss, UT Southwestern researcher reports 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 3Israeli Scientists Recipients of 2008 International Adult Stem Cell Award 5654 1Israeli Scientists Recipients of 2008 International Adult Stem Cell Award 5654 2New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 1New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 2New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 3New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 4Key to Angelina like cheeks 3F Add volume to deep fat compartment 20353 1Key to Angelina like cheeks 3F Add volume to deep fat compartment 20353 2C sections a critical factor in preterm birth increase 20351 1C sections a critical factor in preterm birth increase 20351 2
...University of Pittsburgh Professor of Anthropology...fessor of Biochemistry Bruno Maresca, published Ja... emerging understanding of cell structure lends st...iginally explained in his seminal work, Sudden Ori... (John Wiley & Sons, 2000). , In that book, Sc...
...ree grows widely throughout the country and is kno...mes called "gumballs." Now, this spiny fruit may b...make a lifesaving drug against bird flu ?a drug th...hers say. , Chemists have found that the seeds of ...shikimic acid, the starting material used to produ...
...aths to new therapeutic drugs, as well as a wide a...ted through, of all things, intelligent design. A...tional Laboratory (Berkeley Lab) and the Universit...ique in which the evolution of an important class ..., "We,ve taken enzymes that are promiscuous, meani...
...on in the world’s oceans, primarily caused by agri...velopment of far more male fish than female, there...ding to a study published today on the Web site of...ntal Science & Technology . The study is sched...rnal. , The finding, by Rudolf Wu, Ph.D., and coll...
Other Biology News:Pitt professor's theory of evolution gets boost from cell research 2Pitt professor's theory of evolution gets boost from cell research 3Sweetgum tree could help lessen shortage of bird flu drug 2Intelligently designed molecular evolution 2Intelligently designed molecular evolution 3Ocean 'dead zones' trigger sex changes in fish, posing extinction threat 2
Cytofix/Cytoperm Kit 250 Tests
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:
Anti-MAGE-D2/NRAGE-Like 2b GenBank Accession Number : NM_201222 Immunogen : peptide (C-QSQENQDTRPKVKAKK), corresponding to amino acids 161-176 of human MAGE-D2/NRAGE-Like 2b Formulation: antiserum
Request Info
Biology Products: